Roper (ROP) 10-Q 6 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	3 Months Ended
	Mar. 31, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	Roper Technologies Inc
Entity Central Index Key	882835
Current Fiscal Year End Date	-19
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float		$14,653,055,923
Entity Common Stock, Shares Outstanding	100,521,210
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Earnings (unaudited) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Condensed Consolidated Statements of Earnings (unaudited) [Abstract]
Net sales	$865,281	$834,052
Cost of sales	347,120	345,116
Gross profit	518,161	488,936
Selling, general and administrative expenses	271,265	265,536
Income from operations	246,896	223,400
Interest expense, net	19,836	19,827
Other income/(expense), net	-679	1,420
Earnings before income taxes	226,381	204,993
Income taxes	70,608	57,767
Net earnings	$155,773	$147,226
Earnings per share:
Basic (in dollars per share)	$1.55	$1.48
Diluted (in dollars per share)	$1.54	$1.46
Weighted average common shares outstanding:
Basic (in shares)	100,377	99,557
Diluted (in shares)	101,361	100,572
Dividends declared per common share (in dollars per share)	$0.25	$0.20

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Condensed Consolidated Statements of Comprehensive Income (unaudited) [Abstract]
Net earnings	$155,773	$147,226
Other comprehensive income/(loss), net of tax:
Foreign currency translation adjustments	-92,010	-12,811
Post retirement benefit plan adjustment	1,063	0
Total other comprehensive income/(loss), net of tax	-93,073	-12,811
Comprehensive income	$62,700	$134,415

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (unaudited) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Assets
Cash and cash equivalents	$615,493	$610,430
Accounts receivable, net	499,042	511,538
Inventories, net	194,737	193,766
Deferred taxes	60,020	54,199
Unbilled receivables	107,743	96,409
Other current assets	44,787	45,763
Total current assets	1,521,822	1,512,105
Property, plant and equipment, net	110,973	110,876
Goodwill	5,088,040	4,710,691
Other intangible assets, net	2,142,299	1,978,729
Deferred taxes	35,177	27,496
Other assets	76,311	73,037
Total assets	8,974,622	8,412,934
Liabilities and Stockholders' Equity
Accounts payable	151,139	143,847
Accrued compensation	95,571	117,374
Deferred revenue	237,197	190,953
Other accrued liabilities	169,332	160,738
Income taxes payable	34,934	0
Deferred taxes	3,492	3,943
Current portion of long-term debt, net	7,719	11,092
Total current liabilities	699,384	627,947
Long-term debt, net of current portion	2,617,722	2,203,031
Deferred taxes	759,813	735,826
Other liabilities	90,308	90,770
Total liabilities	4,167,227	3,657,574
Commitments and contingencies (Note 9)
Common stock	1,025	1,021
Additional paid-in capital	1,339,750	1,325,338
Retained earnings	3,650,843	3,520,201
Accumulated other comprehensive earnings	-165,000	-71,927
Treasury stock	-19,223	-19,273
Total stockholders' equity	4,807,395	4,755,360
Total liabilities and stockholders' equity	$8,974,622	$8,412,934

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net earnings	$155,773	$147,226
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment	9,880	9,666
Amortization of intangible assets	38,428	39,037
Amortization of deferred financing costs	1,001	1,002
Non-cash stock compensation	13,801	14,571
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable	20,304	4,582
Unbilled receivables	-11,042	-8,346
Inventories	-7,680	-4,712
Accounts payable and accrued liabilities	8,705	-12,887
Income taxes payable	38,837	24,829
Other, net	-7,608	-2,340
Cash provided by operating activities	260,399	212,628
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	-589,577	-2,146
Capital expenditures	-9,950	-10,478
Proceeds from sale of assets	140	341
Other, net	-3,736	-233
Cash used in investing activities	-603,123	-12,516
Cash flows from financing activities:
Payments under revolving line of credit	415,000	-150,000
Principal payments on senior notes	0	0
Principal payments on convertible notes	-3,454	-433
Cash premiums paid on convertible note conversions	-11,236	-1,174
Cash dividends to stockholders	-25,024	-19,863
Proceeds from stock based compensation, net	6,267	8,026
Stock award tax excess windfall benefit	4,093	7,511
Treasury stock sales	787	729
Other	-289	573
Cash used in financing activities	386,144	-154,631
Effect of foreign currency exchange rate changes on cash	-38,357	-2,316
Net increase in cash and cash equivalents	5,063	43,165
Cash and cash equivalents, beginning of period	610,430	459,720
Cash and cash equivalents, end of period	$615,493	$502,885

Condensed_Consolidated_Stateme3

Condensed Consolidated Statement of Changes in Stockholders' Equity (unaudited) (USD $)	Common stock [Member]	Additional paid-in capital [Member]	Retained earnings [Member]	Accumulated other comprehensive earnings [Member]	Treasury stock [Member]	Total
In Thousands
Beginning Balance at Dec. 31, 2014	$1,021	$1,325,338	$3,520,201	($71,927)	($19,273)	$4,755,360
Net earnings	0	0	155,773	0	0	155,773
Stock option exercises	1	7,383	0	0	0	7,384
Treasury stock sold	0	737	0	0	50	787
Currency translation adjustments, net of tax	0	0	0	-92,010	0	-92,010
Stock based compensation	0	13,801	0	0	0	13,801
Restricted stock activity	3	-1,120	0	0	0	-1,117
Stock option tax benefit, net of shortfalls	0	4,107	0	0	0	4,107
Conversion of senior subordinated convertible notes, net of tax	0	-10,496	0	0	0	-10,496
Dividends declared	0	0	-25,131	0	0	-25,131
Post retirement benefit plan adjustments	0	0	0	-1,063	0	-1,063
Ending Balance at Mar. 31, 2015	$1,025	$1,339,750	$3,650,843	($165,000)	($19,223)	$4,807,395

Condensed_Consolidated_Stateme4

Condensed Consolidated Statement of Changes in Stockholders' Equity (unaudited) (Parenthetical) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Condensed Consolidated Statement of Changes in Stockholders' Equity (unaudited) [Abstract]
Currency translation adjustments, tax	$4,996
Conversion of senior subordinated convertible notes, tax	$740

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2015
Basis of Presentation [Abstract]
Basis of Presentation	1	Basis of Presentation
	Effective April 24, 2015, Roper Industries, Inc. changed its name to Roper Technologies, Inc. in order to reflect its continued evolution to a diversified technology company.
	The accompanying condensed consolidated financial statements for the three month periods ended March 31, 2015 and 2014 are unaudited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Technologies, Inc. and its subsidiaries ("Roper" or the "Company") for all periods presented. The December 31, 2014 financial position data included herein was derived from the audited consolidated financial statements included in the 2014 Annual Report on Form 10-K ("Annual Report") filed on February 20, 2015 with the Securities and Exchange Commission ("SEC") but does not include all disclosures required by U.S. generally accepted accounting principles ("GAAP").
	Roper's management has made estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates.
	The results of operations for the three month period ended March 31, 2015 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited condensed consolidated financial statements in conjunction with Roper's consolidated financial statements and the notes thereto included in its Annual Report.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2015
Recent Accounting Pronouncements [Abstract]
Description of New Accounting Pronouncements Not yet Adopted [Text Block]	2	Recent Accounting Pronouncements
	The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under GAAP in the form of accounting standards updates ("ASUs") to the FASB's Accounting Standards Codification.  The Company considers the applicability and impact of all ASUs.
	In April 2015, the FASB issued an update related to the presentation of debt issuance costs. This update, effective for fiscal years beginning after December 15, 2015, requires that debt issuance costs related to a debt liability be reported in the balance sheet as a direct deduction from the face amount of that debt liability. The Company does not expect this update to have a material impact on its results of operations, financial condition or cash flows.
	In June 2014, the FASB issued updates to the accounting for stock compensation. These updates, effective for fiscal years beginning after December 15, 2015, modify the accounting for share-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. The Company does not expect the updates to have an impact on its results of operations, financial condition or cash flows.
	In May 2014, the FASB issued updates on accounting and disclosures for revenue from contracts with customers. These updates, effective for annual reporting periods after December 15, 2016, create a single, comprehensive revenue recognition model for all contracts with customers. The model is based on changes in contract assets (rights to receive consideration) and liabilities (obligations to provide a good or service). Revenue will be recognized based on the satisfaction of performance obligations, which occurs when control of a good or service transfers to a customer. The Company is evaluating the impact of these updates on its results of operations, financial condition and cash flows.

Business_Acquisitions

Business Acquisitions	3 Months Ended
	Mar. 31, 2015
Business Acquisitions [Abstract]
Business Acquisitions [Text Block]	4.    Business Acquisitions
	During the quarter ended March 31, 2015, Roper acquired 100% of the shares of Strata Decision Technology LLC, a provider of planning and budget software for health care providers, SoftWriters Inc., a provider of long-term care pharmacy operating software, and Data Innovations LLC, a provider of clinical and blood laboratory middleware.  These acquisitions, purchased for $590 million of cash, will expand Roper's existing medical platforms.  All three companies are reported in the Medical & Scientific Imaging segment.  Supplemental pro forma information has not been provided as the acquisitions were immaterial both individually and in aggregate.
	During the three month period ended March 31, 2015, the Company expensed transaction costs of $1.8 million related to the acquisitions as corporate general and administrative expenses, as incurred.
	The Company recorded $418 million in goodwill and $212 million of other identifiable intangibles in connection with the acquisitions; however, purchase price allocations are preliminary pending final intangibles valuations and tax-related adjustments.  Of the $212 million intangible assets acquired, $20 million was assigned to trade names that are not subject to amortization.  The remaining $192 million of acquired intangible assets have a weighted average useful life of 17 years.  The intangible assets that make up that amount include customer relationships of $153 million (19 year weighted average useful life) and software of $39 million (6 year weighted average useful life).

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share	3	Earnings Per Share
	Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are shown below (in thousands):
			Three months ended
			March 31,
			2015		2014
	Basic shares outstanding			100,377		99,557
	Effect of potential common stock
	Common stock awards			852		864
	Senior subordinated convertible notes			132		151
	Diluted shares outstanding			101,361		100,572
	For the three months ended March 31, 2015 there were 697,555 outstanding stock options that were not included in the determination of diluted earnings per share because doing so would have been antidilutive, as compared to 1,093,600 outstanding stock options that would have been antidilutive for the three months ended March 31, 2014.

Stock_Based_Compensation

Stock Based Compensation	3 Months Ended
	Mar. 31, 2015
Stock Based Compensation [Abstract]
Stock-Based Compensation	5	Stock Based Compensation
	The Roper Technologies, Inc. Amended and Restated 2006 Incentive Plan is a stock-based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper's employees, officers and directors.
	Roper's stock purchase plan allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper's common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. Common stock sold to employees may be either treasury stock, stock purchased on the open market, or newly issued shares.
	The following table provides information regarding the Company's stock-based compensation expense (in thousands):
		Three months ended
		March 31,
		2015			2014
	Stock based compensation		$	13,801		$	14,571
	Tax effect recognized in net income			4,830			5,100
	Windfall tax benefit, net			4,107			7,485
	Stock Options - In the three months ended March 31, 2015, 537,555 options were granted with a weighted average fair value of $33.76 per option. During the same period in 2014, 533,000 options were granted with a weighted average fair value of $35.14 per option. All options were issued at grant date fair value, which is defined by the Plan as the closing price of Roper's common stock on the date of grant.
	Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during current and prior year quarters using the Black-Scholes option-pricing model:
			Three Months Ended March 31,
			2015			2014
	Risk-free interest rate (%)			1.51			1.62
	Expected option life (years)			5.1			5.24
	Expected volatility (%)			22.28			27.62
	Expected dividend yield (%)			0.63			0.59
	Cash received from option exercises for the three months ended March 31, 2015 and 2014 was $7.4 million and $10.0 million, respectively.
	Restricted Stock Awards - During the three months ended March 31, 2015, 304,175 restricted stock awards were granted with a weighted average grant date fair value of $149.66 per restricted share. During the same period in 2014, 237,001 restricted stock awards were granted with a weighted average grant date fair value of $139.62 per restricted share. All grants were issued at grant date fair value.
	During the three months ended March 31, 2015, 26,686 restricted awards vested with a weighted average grant date fair value of $124.27 per restricted share, and a weighted average vest date fair value of $157.59 per restricted share.
	Employee Stock Purchase Plan - During the three months ended March 31, 2015 and 2014, participants of the employee stock purchase plan purchased 5,042 and 5,664 shares, respectively, of Roper's common stock for total consideration of $0.79 million and $0.73 million, respectively. All shares were purchased from Roper's treasury shares.

Inventories

Inventories	3 Months Ended
	Mar. 31, 2015
Inventories [Abstract]
Inventories	6	Inventories
	The components of inventory were as follows (in thousands):
			March 31,			December 31,
			2015			2014
	Raw materials and supplies		$	125,529		$	124,103
	Work in process			27,046			29,358
	Finished products			74,978			79,184
	Inventory reserves			(32,816	)		(38,879	)
			$	194,737		$	193,766

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2015
Goodwill and Other Intangible Assets [Abstract]
Goodwill and Other Intangible Assets	7	Goodwill and Other Intangible Assets
	The carrying value of goodwill by segment was as follows (in thousands):
			Medical &			RF Technology			Industrial			Energy Systems			Total
			Scientific Imaging						Technology			& Controls
	Balances at December 31, 2014		$	2,594,356		$	1,280,788		$	408,964		$	426,583		$	4,710,691
	Goodwill acquired			418,207			-			-			-			418,207
	Currency translation adjustments			(14,177	)		(5,742	)		(14,368	)		(6,571	)		(40,858	)
	Balances at March 31, 2015		$	2,998,386		$	1,275,046		$	394,596		$	420,012		$	5,088,040
	Other intangible assets were comprised of (in thousands):
			Cost			Accumulated			Net book
						amortization			value
	Assets subject to amortization:
	Customer related intangibles		$	1,975,334		$	(543,594	)	$	1,431,740
	Unpatented technology			217,260			(134,702	)		82,558
	Software			156,449			(62,882	)		93,567
	Patents and other protective rights			26,463			(18,325	)		8,138
	Backlog			1,100			(443	)		657
	Trade names			622			(72	)		550
	Assets not subject to amortization:
	Trade names			361,519			-			361,519
	Balances at December 31, 2014		$	2,738,747		$	(760,018	)	$	1,978,729
	Assets subject to amortization:
	Customer related intangibles		$	2,067,106		$	(516,024	)	$	1,551,082
	Unpatented technology			173,527			(98,136	)		75,391
	Software			160,597			(31,978	)		128,619
	Patents and other protective rights			24,682			(17,278	)		7,404
	Backlog			1,100			(718	)		382
	Trade names			594			(82	)		512
	Assets not subject to amortization:
	Trade names			378,909			-			378,909
	Balances at March 31, 2015		$	2,806,515		$	(664,216	)	$	2,142,299
	Amortization expense of other intangible assets was $37,859 and $38,049 during the three months ended March 31, 2015 and 2014, respectively.
	An evaluation of the carrying value of goodwill and indefinite-lived intangibles is required to be performed on an annual basis and on an interim basis if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. There have been no events or changes in circumstances which indicate an interim impairment review is required in 2015. The Company expects to perform the annual analysis during the fourth quarter.

Debt

Debt	3 Months Ended
	Mar. 31, 2015
Debt [Abstract]
Debt	8	Debt
	Roper's 3.75% senior subordinated convertible notes due 2034 became convertible on January 15, 2009.  During the three months ended March 31, 2015, 6,963 notes were converted by note holders for $14.7 million in cash.  No gain or loss was recorded upon these conversions.  In addition, a related $0.7 million deferred tax liability associated with excess deductions recorded for tax purposes was relieved to additional paid-in capital upon the conversions.
	At March 31, 2015, the conversion price on the remaining outstanding notes was $497.14 per note.  If converted at March 31, 2015, the value would have exceeded the $5 million principal amount of the outstanding notes by $16 million and could have resulted in the issuance of 90,835 shares of Roper's common stock.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2015
Fair Value of Financial Instruments [Abstract]
Fair Value of Financial Instruments	9	Fair Value of Financial Instruments
	Roper's debt at March 31, 2015 included $2.2 billion of fixed-rate senior notes with the following fair values (in millions):
	$400 million senior notes due 2017		$	403
	$800 million senior notes due 2018			803
	$500 million senior notes due 2019			580
	$500 million senior notes due 2022			499
	The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.  Short-term debt at March 31, 2015 included $5 million of fixed-rate convertible notes which were at fair value due to the ability of note holders to exercise the conversion option of the notes.

Contingencies

Contingencies	3 Months Ended
	Mar. 31, 2015
Contingencies [Abstract]
Contingencies	10	Contingencies
	Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including product liability and employment practices. It is vigorously contesting all lawsuits that, in general, are based upon claims of the kind that have been customary over the past several years. After analyzing the Company's contingent liabilities on a gross basis and, based upon past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper's consolidated financial position, results of operations or cash flows.
	Over recent years there has been an increase in certain U.S. states in asbestos-related litigation claims against numerous industrial companies. Roper or its subsidiaries have been named defendants in some such cases. No significant resources have been required by Roper to respond to these cases and the Company believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.
	Roper's financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized. A summary of the warranty accrual activity for the three months ended March 31, 2015 is presented below (in thousands):
	Balance at December 31, 2014		$	9,537
	Additions charged to costs and expenses			2,011
	Deductions			(2,878	)
	Other			(227	)
	Balances at March 31, 2015		$	8,443

Business_Segments

Business Segments	3 Months Ended
	Mar. 31, 2015
Business Segments [Abstract]
Business Segments	11	Business Segments
	Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):
			Three months ended March 31,
			2015		2014		Change
	Net sales:
	Medical & Scientific Imaging		$	291,700	$	256,199		13.9	%
	RF Technology			242,954		225,681		7.7	%
	Industrial Technology			190,728		197,001		(3.2	)%
	Energy Systems & Controls			139,899		155,171		(9.8	)%
	Total		$	865,281	$	834,052		3.7	%
	Gross profit:
	Medical & Scientific Imaging		$	215,326	$	184,850		16.5	%
	RF Technology			130,046		119,651		8.7	%
	Industrial Technology			95,242		98,470		(3.3	)%
	Energy Systems & Controls			77,547		85,965		(9.8	)%
	Total		$	518,161	$	488,936		6	%
	Operating profit*:
	Medical & Scientific Imaging		$	107,779	$	89,771		20.1	%
	RF Technology			73,977		62,560		18.2	%
	Industrial Technology			57,897		56,056		3.3	%
	Energy Systems & Controls			30,422		37,025		(17.8	)%
	Total		$	270,075	$	245,412		10	%
	Long-lived assets:
	Medical & Scientific Imaging		$	36,347	$	39,948		(9.0	)%
	RF Technology			29,585		29,714		(0.4	)%
	Industrial Technology			44,697		49,022		(8.8	)%
	Energy Systems & Controls			15,177		18,503		(18.0	)%
	Total		$	125,806	$	137,187		(8.3	)%
	* Segment operating profit is before unallocated corporate general and administrative expenses of $23,179 and $22,012 for the three months ended March 31, 2015 and 2014, respectively.

Earnings_Per_Share_Policies

Earnings Per Share (Policies)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share Policy	Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are shown below (in thousands):

Stock_Based_Compensation_Polic

Stock Based Compensation (Policies)	3 Months Ended
	Mar. 31, 2015
Stock Based Compensation [Abstract]
Stock Based Compensation	Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during current and prior year quarters using the Black-Scholes option-pricing model:

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Schedule Of Weighted Average Number Of Shares Outstanding Basic To Diluted		Three months ended
		March 31,
		2015		2014
	Basic shares outstanding		100,377		99,557
	Effect of potential common stock
	Common stock awards		852		864
	Senior subordinated convertible notes		132		151
	Diluted shares outstanding		101,361		100,572

Stock_Based_Compensation_Table

Stock Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Stock Based Compensation [Abstract]
Stock Based Compensation Expense	The following table provides information regarding the Company's stock-based compensation expense (in thousands):
		Three months ended
		March 31,
		2015			2014
	Stock based compensation		$	13,801		$	14,571
	Tax effect recognized in net income			4,830			5,100
	Windfall tax benefit, net			4,107			7,485
Weighted average assumptions used to value option grants			Three Months Ended March 31,
			2015			2014
	Risk-free interest rate (%)			1.51			1.62
	Expected option life (years)			5.1			5.24
	Expected volatility (%)			22.28			27.62
	Expected dividend yield (%)			0.63			0.59

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 31, 2015
Inventories [Abstract]
Inventories	The components of inventory were as follows (in thousands):
		March 31,			December 31,
		2015			2014
	Raw materials and supplies	$	125,529		$	124,103
	Work in process		27,046			29,358
	Finished products		74,978			79,184
	Inventory reserves		(32,816	)		(38,879	)
		$	194,737		$	193,766

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill and Other Intangible Assets [Abstract]
Goodwill	The carrying value of goodwill by segment was as follows (in thousands):
		Medical &			RF Technology			Industrial			Energy Systems			Total
		Scientific Imaging						Technology			& Controls
	Balances at December 31, 2014	$	2,594,356		$	1,280,788		$	408,964		$	426,583		$	4,710,691
	Goodwill acquired		418,207			-			-			-			418,207
	Currency translation adjustments		(14,177	)		(5,742	)		(14,368	)		(6,571	)		(40,858	)
	Balances at March 31, 2015	$	2,998,386		$	1,275,046		$	394,596		$	420,012		$	5,088,040
Other Intangible Assets	Other intangible assets were comprised of (in thousands):
		Cost			Accumulated			Net book
					amortization			value
	Assets subject to amortization:
	Customer related intangibles	$	1,975,334		$	(543,594	)	$	1,431,740
	Unpatented technology		217,260			(134,702	)		82,558
	Software		156,449			(62,882	)		93,567
	Patents and other protective rights		26,463			(18,325	)		8,138
	Backlog		1,100			(443	)		657
	Trade names		622			(72	)		550
	Assets not subject to amortization:
	Trade names		361,519			-			361,519
	Balances at December 31, 2014	$	2,738,747		$	(760,018	)	$	1,978,729
	Assets subject to amortization:
	Customer related intangibles	$	2,067,106		$	(516,024	)	$	1,551,082
	Unpatented technology		173,527			(98,136	)		75,391
	Software		160,597			(31,978	)		128,619
	Patents and other protective rights		24,682			(17,278	)		7,404
	Backlog		1,100			(718	)		382
	Trade names		594			(82	)		512
	Assets not subject to amortization:
	Trade names		378,909			-			378,909
	Balances at March 31, 2015	$	2,806,515		$	(664,216	)	$	2,142,299

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2015
Fair Value of Financial Instruments [Abstract]
Fixed-Rate Senior Notes, Fair Value	Roper's debt at March 31, 2015 included $2.2 billion of fixed-rate senior notes with the following fair values (in millions):
	$400 million senior notes due 2017	$	403
	$800 million senior notes due 2018		803
	$500 million senior notes due 2019		580
	$500 million senior notes due 2022		499

Contingencies_Tables

Contingencies (Tables)	3 Months Ended
	Mar. 31, 2015
Contingencies [Abstract]
Warranty Accrual Activity	Roper's financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized. A summary of the warranty accrual activity for the three months ended March 31, 2015 is presented below (in thousands):
	Balance at December 31, 2014	$	9,537
	Additions charged to costs and expenses		2,011
	Deductions		(2,878	)
	Other		(227	)
	Balances at March 31, 2015	$	8,443

Business_Segments_Tables

Business Segments (Tables)	3 Months Ended
	Mar. 31, 2015
Business Segments [Abstract]
Sales and operating profit by business segment Table	Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):
		Three months ended March 31,
		2015		2014		Change
	Net sales:
	Medical & Scientific Imaging	$	291,700	$	256,199		13.9	%
	RF Technology		242,954		225,681		7.7	%
	Industrial Technology		190,728		197,001		(3.2	)%
	Energy Systems & Controls		139,899		155,171		(9.8	)%
	Total	$	865,281	$	834,052		3.7	%
	Gross profit:
	Medical & Scientific Imaging	$	215,326	$	184,850		16.5	%
	RF Technology		130,046		119,651		8.7	%
	Industrial Technology		95,242		98,470		(3.3	)%
	Energy Systems & Controls		77,547		85,965		(9.8	)%
	Total	$	518,161	$	488,936		6	%
	Operating profit*:
	Medical & Scientific Imaging	$	107,779	$	89,771		20.1	%
	RF Technology		73,977		62,560		18.2	%
	Industrial Technology		57,897		56,056		3.3	%
	Energy Systems & Controls		30,422		37,025		(17.8	)%
	Total	$	270,075	$	245,412		10	%
	Long-lived assets:
	Medical & Scientific Imaging	$	36,347	$	39,948		(9.0	)%
	RF Technology		29,585		29,714		(0.4	)%
	Industrial Technology		44,697		49,022		(8.8	)%
	Energy Systems & Controls		15,177		18,503		(18.0	)%
	Total	$	125,806	$	137,187		(8.3	)%
	* Segment operating profit is before unallocated corporate general and administrative expenses of $23,179 and $22,012 for the three months ended March 31, 2015 and 2014, respectively.

Business_Acquisitions_Details

Business Acquisitions (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
	Business
Business Acquisition [Line Items]
Goodwill	$5,088,040,000	$4,710,691,000
Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Number of business acquired	3
Cost of Acquired Entity Purchase Price	590,000,000
Intangible Assets Other than Goodwill	212,000,000
Goodwill	418,000,000
Cost of Acquired Entity Transaction Costs	1,800,000
Finite lived intangible assets	192,000,000
Indefinite lived intangible assets	20,000,000
Weighted average useful life	17 years
Series of Individually Immaterial Business Acquisitions [Member] | Customer Relationships [Member]
Business Acquisition [Line Items]
Finite lived intangible assets	153,000,000
Weighted average useful life	19 years
Series of Individually Immaterial Business Acquisitions [Member] | Software [Member]
Business Acquisition [Line Items]
Finite lived intangible assets	$39,000,000
Weighted average useful life	6 years

Earnings_Per_Share_Details

Earnings Per Share (Details)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Schedule Of Weighted Average Number Of Shares Outstanding Basic To Diluted [Abstract]
Basic shares outstanding (in shares)	100,377,000	99,557,000
Effect of potential common stock [Abstract]
Common stock awards (in shares)	852,000	864,000
Senior subordinated convertible notes (in shares)	132,000	151,000
Diluted shares outstanding (in shares)	101,361,000	100,572,000
Antidilutive stock options (in shares)	697,555	1,093,600

Stock_Based_Compensation_Detai

Stock Based Compensation (Details) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Stock Based Compensation [Abstract]
Percentage of eligible earnings to purchase common stock through the employee stock purchase plan (in hundredths)	10.00%
Discount on the average closing price for the employee stock purchase plan (in hundredths)	5.00%
Stock Based Compensation Expense [Abstract]
Stock based compensation	$13,801,000	$14,571,000
Tax effect recognized in net income	4,830,000	5,100,000
Windfall tax benefit/(shortfall), net	4,107,000	7,485,000
Employee stock options granted during the period (in shares)	537,555	533,000
Fair value per share (in dollars per share)	$33.76	$35.14
Weighted average assumptions used to value option grants [Abstract]
Risk-free interest rate (%) (in hundredths)	1.51%	1.62%
Expected option life (years)	5 years 1 month 6 days	5 years 2 months 26 days
Expected volatility (%) (in hundredths)	22.28%	27.62%
Expected dividend yield (%) (in hundredths)	0.63%	0.59%
Cash received from exercise of options	7,400,000	10,000,000
Restricted stock awards granted during period (in shares)	304,175	237,001
Weighted average fair value per share of restricted stock awards granted during the period (in dollars per share)	$149.66	$139.62
Restricted stock awards vested during period (in shares)	26,686
Weighted average grant date fair value per share (in dollars per share)	$124.27
Weighted average vest date fair value per share (in dollars per share)	$157.59
Shares of stock purchased during the period by participants in the employee stock purchase plan (in shares)	5,042	5,664
Amount paid for stock purchased during the period by participants in the employee stock purchase plan	$790,000	$730,000

Inventories_Details

Inventories (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Inventories [Abstract]
Raw materials and supplies	$125,529	$124,103
Work in process	27,046	29,358
Finished products	74,978	79,184
Inventory reserves	-32,816	-38,879
Total Inventory	$194,737	$193,766

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Goodwill [Line Items]
Balances	$4,710,691
Goodwill acquired	418,207
Goodwill, Other Changes	0
Currency translation adjustments	-40,858
Balances	5,088,040
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	2,806,515		2,738,747
Accumulated amortization	-664,216		-760,018
Net book value	2,142,299		1,978,729
Amortization expense of other intangible assets	37,859	38,049
Assets subject to amortization [Member] | Customer related intangibles [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	2,067,106		1,975,334
Accumulated amortization	-516,024		-543,594
Net book value	1,551,082		1,431,740
Assets subject to amortization [Member] | Unpatented technology [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	173,527		217,260
Accumulated amortization	-98,136		-134,702
Net book value	75,391		82,558
Assets subject to amortization [Member] | Software [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	160,597		156,449
Accumulated amortization	-31,978		-62,882
Net book value	128,619		93,567
Assets subject to amortization [Member] | Patents and other protective rights [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	24,682		26,463
Accumulated amortization	-17,278		-18,325
Net book value	7,404		8,138
Assets subject to amortization [Member] | Order or Production Backlog [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	1,100		1,100
Accumulated amortization	-718		-443
Net book value	382		657
Assets subject to amortization [Member] | Trade names [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	594		622
Accumulated amortization	-82		-72
Net book value	512		550
Assets not subject to amortization [Member] | Trade names [Member]
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	378,909		361,519
Accumulated amortization	0		0
Net book value	378,909		361,519
Industrial Technology [Member]
Goodwill [Line Items]
Balances	408,964
Goodwill acquired	0
Currency translation adjustments	-14,368
Balances	394,596
Energy Systems And Controls [Member]
Goodwill [Line Items]
Balances	426,583
Goodwill acquired	0
Currency translation adjustments	-6,571
Balances	420,012
Medical And Scientific Imaging [Member]
Goodwill [Line Items]
Balances	2,594,356
Goodwill acquired	418,207
Currency translation adjustments	-14,177
Balances	2,998,386
RF Technology [Member]
Goodwill [Line Items]
Balances	1,280,788
Goodwill acquired	0
Currency translation adjustments	-5,742
Balances	$1,275,046

Debt_Details

Debt (Details) (Senior Subordinated Convertible Notes [Member], USD $)	3 Months Ended
In Millions, except Share data, unless otherwise specified	Mar. 31, 2015
	NotesConverted
Senior Subordinated Convertible Notes [Member]
Debt Instrument [Line Items]
Stated Interest Rate Percentage - Debt Instruments (in hundredths)	3.75%
Maturity year of Senior subordinated convertible notes	2034
First Conversion Date	15-Jan-09
Number of Notes Converted	6,963
Cash Payments for Debt Conversions (in millions)	$14.70
Deferred Tax Liability (in millions)	0.74
Per Note Conversion Price (in dollars per share)	$497.14
Principal note amount (in millions)	5
Excess above Principal Note Amount (in millions)	$16
If converted, issuance of common stock shares (in shares)	90,835

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015
Convertible Notes [Member]
Short-term Debt [Line Items]
Fair Value of Debt Instrument	$5
Fair Value, Inputs, Level 2 [Member]
Debt Instrument [Line Items]
Face Value of Debt Instrument	2,200
Fair Value, Inputs, Level 2 [Member] | Senior notes due 2017 [Member]
Debt Instrument [Line Items]
Face Value of Debt Instrument	400
Long-term Debt, Fair Value	403
Notes due	2017
Fair Value, Inputs, Level 2 [Member] | Senior notes due 2018 [Member]
Debt Instrument [Line Items]
Face Value of Debt Instrument	800
Long-term Debt, Fair Value	803
Notes due	2018
Fair Value, Inputs, Level 2 [Member] | Senior notes due 2019 [Member]
Debt Instrument [Line Items]
Face Value of Debt Instrument	500
Long-term Debt, Fair Value	580
Notes due	2019
Fair Value, Inputs, Level 2 [Member] | Senior notes due 2022 [Member]
Debt Instrument [Line Items]
Face Value of Debt Instrument	500
Long-term Debt, Fair Value	$499
Notes due	2022

Contingencies_Details

Contingencies (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Warranty Accrual Activity [Roll Forward]
Balance	$9,537
Additions charged to costs and expenses	2,011
Deductions	-2,878
Other	-227
Balance	$8,443

Business_Segments_Details

Business Segments (Details) (USD $)	3 Months Ended
	Mar. 31, 2015		Mar. 31, 2014
Segment Reporting Information [Line Items]
Net sales	$865,281,000		$834,052,000
Percent change in Net Sales (in hundredths)	3.70%
Gross Profit	518,161,000		488,936,000
Percent change in Gross Profit (in hundredths)	6.00%
Operating profit	270,075,000	[1]	245,412,000	[1]
Percent change in Operating Profit (in hundredths)	10.00%	[1]
Long-Lived assets	125,806,000		137,187,000
Percent change in Long-lived assets (in hundredths)	-8.30%
Unallocated corporate general and administrative expenses	23,179	[1]	22,012	[1]
Industrial Technology [Member]
Segment Reporting Information [Line Items]
Net sales	190,728,000		197,001,000
Percent change in Net Sales (in hundredths)	-3.20%
Gross Profit	95,242,000		98,470,000
Percent change in Gross Profit (in hundredths)	-3.30%
Operating profit	57,897,000	[1]	56,056,000	[1]
Percent change in Operating Profit (in hundredths)	3.30%	[1]
Long-Lived assets	44,697,000		49,022,000
Percent change in Long-lived assets (in hundredths)	-8.80%
Energy Systems And Controls [Member]
Segment Reporting Information [Line Items]
Net sales	139,899,000		155,171,000
Percent change in Net Sales (in hundredths)	-9.80%
Gross Profit	77,547,000		85,965,000
Percent change in Gross Profit (in hundredths)	-9.80%
Operating profit	30,422,000	[1]	37,025,000	[1]
Percent change in Operating Profit (in hundredths)	-17.80%	[1]
Long-Lived assets	15,177,000		18,503,000
Percent change in Long-lived assets (in hundredths)	-18.00%
Medical And Scientific Imaging [Member]
Segment Reporting Information [Line Items]
Net sales	291,700,000		256,199,000
Percent change in Net Sales (in hundredths)	13.90%
Gross Profit	215,326,000		184,850,000
Percent change in Gross Profit (in hundredths)	16.50%
Operating profit	107,779,000	[1]	89,771,000	[1]
Percent change in Operating Profit (in hundredths)	20.10%	[1]
Long-Lived assets	36,347,000		39,948,000
Percent change in Long-lived assets (in hundredths)	-9.00%
RF Technology [Member]
Segment Reporting Information [Line Items]
Net sales	242,954,000		225,681,000
Percent change in Net Sales (in hundredths)	7.70%
Gross Profit	130,046,000		119,651,000
Percent change in Gross Profit (in hundredths)	8.70%
Operating profit	73,977,000	[1]	62,560,000	[1]
Percent change in Operating Profit (in hundredths)	18.20%	[1]
Long-Lived assets	$29,585,000		$29,714,000
Percent change in Long-lived assets (in hundredths)	-0.40%
[1]	Segment operating profit is before unallocated corporate general and administrative expenses. These expenses were $23,179 and $22,012 for the three months ended March 31, 2015 and 2014, respectively.